Antiviral technology from Microban makes it impossible for viruses to replicate or survive on surfaces. This provides producers with a useful product feature, as well as increased satisfaction to consumers.
Fremont, CA: The COVID-19 pandemic has encouraged the demand for antiviral measures and treatments for clean surfaces, particularly in public settings. Multiple-barrier protection is frequently required, and in addition to high cleanliness standards and vaccination programs, a variety of control measures, such as sufficient personal protective equipment (PPE) or antiviral surfaces in public places are critical to reducing virus transmission. Microban International is introducing a new line of antiviral technologies that have been shown to lower viral load on products and surfaces. Microban has long been a reliable partner in a variety of industries, from consumer to healthcare to industrial and construction, and this announcement adds to the company's technological portfolio's adaptability.
Microban technology can be introduced into a variety of materials throughout the production process, forming a permanent part of the product's structure to give inherent and long-lasting antimicrobial protection. Microban's new antiviral technologies have been found to meet the requirements of both ISO 18184, which evaluates the antiviral performance of treated textile products such as woven and knitted fabrics, fibers, yarns, and braids, and ISO 21702, which assesses activity in treated plastics and other non-porous surfaces. The efficacy of each product type was thoroughly tested against a variety of viruses, including bacteriophage Phi6, a key surrogate virus for SARS-CoV-2. According to the findings, articles treated with these technologies can now benefit from a 99 percent reduction in viral loading.
Following the outbreak of the COVID-19 pandemic, there was a massive increase in demand for antiviral technology in products, and Microban is well aware that it was not the first company to make antiviral claims. Instead, the company spent significant time and resources ensuring that its antiviral technologies were not only scientifically proven to reduce viral loading on surfaces and products but also that they could be used in a regulatory-compliant manner by brands and manufacturers across a wide range of territories and product types. Microban is dedicated to being a dependable and trustworthy industry leader, and its unrivaled regulatory experience can assist partners in understanding the consequences of antiviral claims on their product types in the countries where they are sold.